Methylprednisolone Completed Phase 3 Trials for Leukemias Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00002534Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission